×
Please click
here
if you are not redirected within a few seconds.
All
News
Videos
Images
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Avacta Group Announces AGM and Yearly Report - TipRanks.com
Tipranks
Avacta Group plc (GB:AVCT) has released an update. Avacta Group plc, a life sciences company specializing in targeted oncology drugs and diagnostics,...
5 days ago
Avacta Group (LON:AVCT) Reaches New 1-Year Low at $40.40
Defense World
Avacta Group Plc (LON:AVCT – Get Free Report)'s stock price reached a new 52-week low during trading on Friday . The stock traded as low as...
2 days ago
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update
GlobeNewswire
AVA6000, Avacta Therapeutics' lead oncology program, is a peptide drug conjugate consisting of doxorubicin conjugated with a peptide moiety that...
2 months ago
Avacta Group Plc (LON:AVCT) is a favorite amongst institutional investors who own 53%
Yahoo Finance
Every investor in Avacta Group Plc (LON:AVCT) should be aware of the most powerful shareholder groups. We can see that institutions own the...
3 months ago
Avacta Group PLC (AVCTF) Q4 2023 Earnings Call Transcript
Seeking Alpha
Avacta Group PLC (OTCPK:AVCTF) Q4 2023 Earnings Conference Call April 30, 2024 7:30 AM ETCompany ParticipantsChristina Coughlin - CEOTony...
1 month ago
Avacta reports further progress in chemotherapy trial
Sharecast.com
Avacta Group announced the successful completion of the first cohort and the start of dosing for three patients in the second cohort of the...
2 weeks ago
Investors Give Avacta Group Plc (LON:AVCT) Shares A 26% Hiding
Simply Wall Street
To us, it seems Avacta Group currently trades on a significantly depressed P/S given its forecasted revenue growth is higher than the rest of...
3 months ago
Avacta Group - FY23 results, Chris Coughlin appointed CEO
Research Tree
Avacta Group - FY23 results, Chris Coughlin appointed CEO ... Avacta reported results for FY23 but more importantly announced the appointment of...
1 month ago
Down 63% in 2024, what's going on with the Avacta (AVCT) share price?
Fool UK
2024 has been a difficult year for many companies in the biotechnology sector, with the AVCT share price down heavily.
2 weeks ago
Avacta Group Plc, (LON:AVCT) Share Price, RNS News and Interviews
DirectorsTalk Interviews
Avacta is developing novel cancer immunotherapies combining its two proprietary platforms – Affimer® biotherapeutics and pre|CISIONTM tumour targeted...
6 days ago